Product Information
METHYLDOPA 250 MG TABLET is a generic product labeled by Chartwell RX LLC, priced at $7.4999 per EA under NDC 62135032190. Its NADAC has been published 70 times since Mar 19, 2025.
FDA first approved this application on Jun 29, 1984.
Strength
250 mg/1
Manufacturer
Chartwell RX LLCNDC
62135032190
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
7/23/2025
Active Ingredients
METHYLDOPAApproval Type
Authorized Generic (NDA)
FDA Application
NDA018934FDA Approved
6/29/1984
On Market Since
6/29/1984
Pharmacological Classes
Price Statistics
The NADAC for METHYLDOPA 250 MG TABLET has been published 70 times since Mar 19, 2025, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $7.4999 per EA |
|---|---|
| All-time high | $7.4999 (Jul 15, 2026) |
| All-time low | $7.4999 (Mar 19, 2025) |
| 52-week high | $7.4999 |
| 52-week low | $7.4999 |
| Median price | $7.4999 |
| Average price | $7.4999 |
| Largest weekly change | 0.0% (Mar 26, 2025) |
| Weeks tracked | 70 |
| Tracking since | Mar 19, 2025 |
1W
N/A
1M
N/A
3M
0.0%
6M
0.0%
1Y
0.0%
3Y
N/A
5Y
N/A
All
0.0%
Last surveyed Jul 15, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of METHYLDOPA 250 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for METHYLDOPA 250 MG TABLET, manufactured by Chartwell RX LLC, is $7.4999 per EA (NDC 62135032190), effective Jul 15, 2026.
How has the price of METHYLDOPA 250 MG TABLET changed over time?
Over the history we have for it, the NADAC for METHYLDOPA 250 MG TABLET has held within roughly two percent of its current level. It has been tracked across 70 weekly CMS publications since Mar 19, 2025.
What are the highest and lowest recorded NADAC prices for METHYLDOPA 250 MG TABLET?
Since Mar 19, 2025, the NADAC for METHYLDOPA 250 MG TABLET has ranged from a low of $7.4999 (Mar 19, 2025) to a high of $7.4999 (Jul 15, 2026), with a median of $7.4999 per EA.
Are there cheaper alternatives to METHYLDOPA 250 MG TABLET?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as METHYLDOPA 250 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures METHYLDOPA 250 MG TABLET?
METHYLDOPA 250 MG TABLET (NDC 62135032190) is labeled by Chartwell RX LLC, and CMS classifies it as a generic product.